Order Article Reprints

Hsu Y-H, Zheng C-M, Chou C-L, Chen Y-J, Lee Y-H, Lin Y-F, Chiu H-W. Therapeutic Effect of Endothelin-Converting Enzyme Inhibitor on Chronic Kidney Disease through the Inhibition of Endoplasmic Reticulum Stress and the NLRP3 Inflammasome. Biomedicines. 2021; 9(4):398. https://doi.org/10.3390/biomedicines9040398

Hsu, Yung-Ho, Cai-Mei Zheng, Chu-Lin Chou, Yi-Jie Chen, Yu-Hsuan Lee, Yuh-Feng Lin, and Hui-Wen Chiu. 2021. "Therapeutic Effect of Endothelin-Converting Enzyme Inhibitor on Chronic Kidney Disease through the Inhibition of Endoplasmic Reticulum Stress and the NLRP3 Inflammasome" Biomedicines 9, no. 4: 398. https://doi.org/10.3390/biomedicines9040398

Hsu, Y.-H., Zheng, C.-M., Chou, C.-L., Chen, Y.-J., Lee, Y.-H., Lin, Y.-F., & Chiu, H.-W. (2021). Therapeutic Effect of Endothelin-Converting Enzyme Inhibitor on Chronic Kidney Disease through the Inhibition of Endoplasmic Reticulum Stress and the NLRP3 Inflammasome. Biomedicines, 9(4), 398. https://doi.org/10.3390/biomedicines9040398